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Abstract
Background: Distinguishing an atypical lipomatous tumor/well-differentiated liposarcoma from a benign lipomatous
tumor on morphology alone can be difficult and there is an established role for MDM2 fluorescent in situ hybridization
studies in making this differential diagnosis. There is no literature on the role for MDM2 fluorescent in situ hybridization
studies in distinguishing between a well-differentiated liposarcoma with extreme fibrosis and a fibrosing inflammatory
pseudotumor.
Case presentation: We report the case of a 76-year-old Australian woman initially diagnosed by an excision biopsy
with a retroperitoneal fibrosing inflammatory pseudotumor. She was then diagnosed 5 years later with a pleomorphic
undifferentiated sarcoma. Upon review of the original resection specimen, we were able to show that the tumor
demonstrated MDM2 amplification. MDM2 amplification was also present in some adjacent bland adipose tissue, and
also in the tumor recurrence as a pleomorphic undifferentiated sarcoma.
Conclusion: Taken together, our findings provide strong evidence that the original tumor was a misdiagnosed well-
differentiated liposarcoma with extreme fibrosis, and the pleomorphic undifferentiated sarcoma represented a
recurrence of the same tumor with dedifferentiation.
Keywords: Benign lipomatous tumor, Liposarcoma, MDM2
Background
The distinction between atypical lipomatous tumor/well-
differentiated liposarcoma (ALT/WDLPS) and benign li-
pomatous tumors can be difficult, and fluorescent in situ
hybridization (FISH) studies for MDM2 amplification
have an established role in the pathological differential
diagnosis [1–8]. Distinguishing between WDLPS with
extreme sclerosis and fibrosing inflammatory pseudotu-
mor can be equally problematic, but FISH studies for
MDM2 are infrequently used in this setting. We present
a case of low grade liposarcoma initially misdiagnosed as
a fibrosing retroperitoneal pseudotumor and discuss the
utility of MDM2 FISH in establishing a definitive tissue
diagnosis.
Case presentation
Our patient was a 76-year-old Caucasian Australian
woman who originally presented over 5 years ago with
urinary symptoms initially suggestive of recurrent urin-
ary tract infection. At that time, she had an unremark-
able past medical history of mild hypertension with no
previous hospitalizations and did not smoke cigarettes.
She underwent a work-up for the ongoing dysuria and
urgency symptoms and imaging demonstrated a high-
density retroperitoneal tumor with some fat density
around her right inguinal canal. This tumor was surgi-
cally resected. On gross examination, the retroperitoneal
tumor was 10 cm in diameter with a lobulated contour
and a pale whorled cut surface reminiscent of uterine
leiomyoma. On histological examination, there was
widespread, dense fibrosis, with a variable chronic in-
flammatory infiltrate rich in plasma cells that was most
prominent at the periphery of the tumor (Fig. 1a). The
tumor was hypocellular and densely fibrotic, composed
predominantly of bland stromal cells with morphology
suggestive of fibroblasts (Fig. 1b, c). Very occasional
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mildly atypical larger cells were noted and some were
vacuolated (Fig. 1b, c), but no diagnostic lipoblasts were
identified. The fat from her right inguinal canal was
composed of mature adipose tissue with extensive fat
necrosis. Again, no lipoblasts were identified. Immuno-
histochemistry demonstrated that the tumor was nega-
tive for S100, CD34, cKit, desmin, and anaplastic
lymphoma kinase (ALK), and there was no increase in
immunoglobulin (Ig)G4-positive plasma cells. Although
there was some uncertainty, the retroperitoneal tumor
was diagnosed as an inflammatory pseudotumor in fibros-
ing stage (IgG4-negative variant). The area of fat necrosis
in her right inguinal canal was considered benign.
Our patient re-presented 5 years later with similar
urinary symptoms and imaging demonstrated a retro-
peritoneal tumor at the site of the previous excision. She
underwent en block excision with a right hemicolectomy.
The excised tumor was centered in the deep mesocolon.
Again the tumor was lobulated and 10 cm in diameter
with a somewhat pale fleshy cut surface. An incomplete
rim of chronic inflammation was again noted (Fig. 2a)
but the recurrent tumor was composed of poorly differ-
entiated pleomorphic cells including bizarre forms
(Fig. 2b, c). That is, the tumor demonstrated the morph-
ology of a pleomorphic undifferentiated sarcoma. Des-
pite the marked pleomorphism, mitoses were infrequent
(less than 1 per 10 high-power fields). Again, occasional
vacuolated cells were present (Fig. 2c) but classic lipo-
blasts were not identified.
Immunohistochemistry again demonstrated that the
neoplastic cells were negative for S100, CD34, cKit, des-
min, and ALK. Given the identical location and presence
of a rim of inflammatory cells it was clear that the recur-
rence represented dedifferentiation of the primary
Fig. 1 Representative photomicrographs from the initial resection specimen. a The tumor was relatively well circumscribed, with scattered lymphoid
aggregates noted at the edge. b There was extensive fibrosis with scattered inflammatory cells and occasional enlarged cells with vague vacuolation
(arrow). c Upon review, some of these atypical cells (arrow) showed cytoplasmic vacuolation raising the possibility of a lipoblast. d Fluorescent in situ
hybridization studies demonstrated amplification of MDM2 (red signal) compared to the chromosome 12 centromere probe (green signal). Original
magnifications a 20×, b 100×, c 400×, d 1000×
Fig. 2 Representative photomicrographs of the tumor recurrence.
a The tumor was well circumscribed and there was a peripheral rim
of lymphoid aggregates. b At intermediate power, the tumor
demonstrated marked nuclear atypia with morphology reminiscent
of a pleomorphic undifferentiated sarcoma. c Very occasional cells
demonstrated cytoplasmic vacuolation, morphologically suggestive
of an origin from the dedifferentiation of liposarcoma. d Fluorescent
in situ hybridization studies demonstrated amplification of MDM2
(red signal). Original magnifications a 20×, b 100×, c 400×, d 600×
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tumor. Upon review of both cases, the possibility of ded-
ifferentiated liposarcoma was considered. The primary
tumor, the bland adipose tissue resected from the in-
guinal canal at the time of surgery, and the recurrent
tumor all underwent FISH testing, which demonstrated
MDM2 amplification in all three specimens (Figs 1d and
2d). Therefore a final diagnosis of ALT/WDLPS with
subsequent dedifferentiation and recurrence as a dedif-
ferentiated liposarcoma was made.
Discussion
The demonstration of amplification of MDM2 with
FISH has proven to be a robust and reliable method of
differentiating ALT/WDLPS from benign lipomatous tu-
mors [1–8]. For example, Kimura et al. found MDM2
amplification in 98 % (48 of 49) of ALT/WDLPS but in
no benign adipose tumors [1]. Similarly Weaver et al.
demonstrated MDM2 amplification in 100 % of ALT/
WDLPS (13 out of 13) and dedifferentiated liposarcomas
(14 out of 14) [2]. Of note MDM2 amplification has
been consistently demonstrated in areas of WDLPS with
minimal cellular atypia, indicating that the presence of
MDM2 amplification even in cytologically bland adipose
tissue can be considered prima facie evidence of ALT/
WDLPS [2]. That is, if MDM2 FISH studies had been
available and were performed prospectively in our case
at first presentation in 2010, a diagnosis of ALT/WDLPS
could have been justified despite the bland cytology.
There is also emerging evidence that the presence of
MDM2 amplification in an otherwise undifferentiated
sarcoma is strong evidence that the tumor has arisen
from dedifferentiation of a liposarcoma. For example, in
Le Guellec et al. [3] reported that tumors that would
otherwise be classified as pleomorphic undifferentiated
sarcoma, but that demonstrated MDM2 amplification,
had similar clinical characteristics, morphology, genomic
profile, and outcome to conventional dedifferentiated
liposarcoma and were significantly less aggressive than
pleomorphic undifferentiated sarcomas without MDM2
amplification. Our case, which provides clear evidence of
a pleomorphic undifferentiated sarcoma arising from a
lower grade tumor with MDM2 amplification, further
supports this finding.
Conclusion
To exclude ALT/WDLPS, it has been recommended that
MDM2 FISH studies be performed in any atypical adi-
pose tumors, including any adipose tumor with equivo-
cal cytological atypia or cytologically bland tumors with
recurrence, large size, deep location, and/or retroperi-
toneal location [7]. This case demonstrates that there
may also be a role for MDM2 studies to exclude a diag-
nosis of WDLPS with extreme sclerosis in patients
apparently presenting with a retroperitoneal inflamma-
tory pseudotumor.
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